ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.329,94
-0,10%
S&P 500
5.918,25
0,16%
Dow Jones
42.635,20
0,25%
Euro vs US Dollar
1,03159
0,02%
Bitcoin
94.994,35
-0,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Hancock Jaffe Laboratories Inc (HJLI) Börsenkurse

Hancock Jaffe Laboratories Inc

Hancock Jaffe Laboratories Inc (HJLI)

NASDAQ
10,38
0,00
(0,00%)
Geschlossen 09 Januar 10:00PM
Verzögert um 15 Minuten
0,00
0,00
(0,00%)
Nach Börsenschluss: -
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
10,38
Gebot
10,00
Fragen
10,70
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
98,319M
Handelsende
10,38
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
9.472.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,18
Gewinn pro Aktie (EPS)
-2,48
Erlöse
-
Nettogewinn
-23,52M

Über Hancock Jaffe Laboratories Inc

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
www.envveno.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-

HJLI Neueste Nachrichten

Weitere Nachrichten

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

19 Februar 2019
GlobeNewswire Inc.

Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study

IRVINE, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

28 Januar 2019
GlobeNewswire Inc.

Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

15 Januar 2019
GlobeNewswire Inc.

Hancock Jaffe Announces End Points for First-in-Human VenoValve Study

IRVINE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

09 Januar 2019
GlobeNewswire Inc.

Hancock Jaffe Receives Approval for First-in-Human VenoValve Study

IRVINE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

17 Dezember 2018
GlobeNewswire Inc.

Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute

IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

04 Dezember 2018
GlobeNewswire Inc.

Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia

IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

20 November 2018
GlobeNewswire Inc.

Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance

IRVINE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

13 November 2018
GlobeNewswire Inc.

Hancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart Institute

IRVINE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

09 Oktober 2018
GlobeNewswire Inc.

Hancock Jaffe Appoints Three New Independent Directors

Accomplished medical device professionals and nationally recognized fund manager and analystbring key experience to the leadership of cardiac and vascular device company IRVINE, Calif., Oct...

02 Oktober 2018
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

HJLI - Frequently Asked Questions (FAQ)

What is the current Hancock Jaffe Laboratories share price?
The current share price of Hancock Jaffe Laboratories is US$ 10,38
How many Hancock Jaffe Laboratories shares are in issue?
Hancock Jaffe Laboratories has 9.472.000 shares in issue
What is the market cap of Hancock Jaffe Laboratories?
The market capitalisation of Hancock Jaffe Laboratories is USD 98,32M
What is the 1 year trading range for Hancock Jaffe Laboratories share price?
Hancock Jaffe Laboratories has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Hancock Jaffe Laboratories?
The price to earnings ratio of Hancock Jaffe Laboratories is -4,18
What is the reporting currency for Hancock Jaffe Laboratories?
Hancock Jaffe Laboratories reports financial results in USD
What is the latest annual profit for Hancock Jaffe Laboratories?
The latest annual profit of Hancock Jaffe Laboratories is USD -23,52M
What is the registered address of Hancock Jaffe Laboratories?
The registered address for Hancock Jaffe Laboratories is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Hancock Jaffe Laboratories website address?
The website address for Hancock Jaffe Laboratories is www.envveno.com
Which industry sector does Hancock Jaffe Laboratories operate in?
Hancock Jaffe Laboratories operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CURRCurrenc Group Inc
US$ 3,94
(183,45%)
292,68M
SANASana Biotechnology Inc
US$ 4,29
(160,00%)
159,1M
ACCDAccolade Inc
US$ 6,86
(104,78%)
24,84M
VIRVir Biotechnology Inc
US$ 12,48
(58,17%)
39,17M
SILOSilo Pharma Inc
US$ 1,71
(56,88%)
164,01M
DATSDatChat Inc
US$ 3,225
(-63,89%)
10,12M
JSPRJasper Therapeutics Inc
US$ 6,99
(-60,53%)
6,59M
XTIAXTI Aerospace Inc
US$ 0,05
(-56,18%)
603,28M
MMVMultiMetaVerse Holdings Ltd
US$ 0,50
(-48,98%)
1,57M
RGTIRigetti Computing Inc
US$ 10,015
(-45,54%)
299,56M
XTIAXTI Aerospace Inc
US$ 0,05
(-56,18%)
613,23M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0863
(-24,96%)
340,64M
RGTIRigetti Computing Inc
US$ 10,015
(-45,54%)
305,27M
CURRCurrenc Group Inc
US$ 3,94
(183,45%)
293,23M
CDTConduit Pharmaceuticals Inc
US$ 0,0844
(-10,21%)
254,53M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
HJLI
Hancock Jaffe Laboratories
COIN
ALPINEUSD
ALPINE Fan Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten